COMMUNIQUÉS West-GlobeNewswire

Psyence Biomed Announces Registration Statement on Form F-1 for Up to $25 Million Equity Line of Credit with White Lion Capital, LLC, Declared Effective by SEC
30/08/2024
NEW YORK, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced that the registration statement pertaining to its previously announced $25 million [...]
Trading by management and close relations of management
30/08/2024
Please read the full announcement in PDF Attachment 2024_29_Trading_By_Management
BioConnection appoints Dr. Gary M. Phillips as new Chairman of its Supervisory Board
30/08/2024
OSS, The Netherlands – 30 August 2024, BioConnection , a leading Dutch contract development and manufacturing organization (CDMO) in the pharmaceutical industry, today announced the appointment of Dr. Gary M. Phillips [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
30/08/2024
Bagsværd, Denmark, 30 August 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
HUTCHMED Provides Update on Fruquintinib for Second-Line Gastric Cancer in China
30/08/2024
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 30, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has voluntarily withdrawn its supplemental New [...]
Raw Garden Announces End of Summer and Labor Day Deals
30/08/2024
Premier cannabis cultivator offers up to 40% off at participating retailers across California SANTA BARBARA, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Raw Garden , California's premier cannabis cultivator, manufacturer [...]
Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
30/08/2024
AI-generated, compact SMART nucleases demonstrated robust genome editing activity in vitro in mammalian cells at multiple therapeutically relevant loci Compact SMART genome editing tools that fit within delivery [...]
ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split
29/08/2024
The combined company will operate as “Oruka Therapeutics, Inc.” with its common stock traded on Nasdaq under trading symbol “ORKA” effective Tuesday, September 3, 2024 WESTMINSTER, Colo., Aug. 29, 2024 (GLOBE NEWSWIRE [...]
Ultragenyx to Participate in Investor Conferences in September
29/08/2024
Morgan Stanley 22 nd Annual Global Healthcare Conference on September 4 Cantor Global Healthcare Conference on September 17 Bank of America Global Healthcare Conference on September 18 NOVATO, Calif., Aug. 29, 2024 ( [...]
Umoja Biopharma to Participate in Upcoming Investor Conferences in September
29/08/2024
SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR-T cell therapies [...]
StateHouse Reports Second Quarter 2024 Financial Results
29/08/2024
Q2 2024 Net Revenue Increase d 10% to $27.8 Million and Gross Margin Remains Strong at 50.8 % Achieved Positive Net Income of $0.2 Million and Adjusted EBITDA of $4.9 Million in Q2 2024 SAN DIEGO and TORONTO, Aug. 29, [...]
WORK Medical Technology Group LTD Announces Partial Exercise of Underwriters’ Over-Allotment Option
29/08/2024
Hangzhou, China, Aug. 29, 2024 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (the “Company”), a supplier of medical devices in China, today announced the underwriter of its initial public offering [...]
Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment
29/08/2024
Vancouver, Canada, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]
SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination
29/08/2024
TEL AVIV, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders [...]
Kane Biotech Announces Second Quarter 2024 Financial Results
29/08/2024
Company Realizes $10.4M Gain on the Sale of STEM WINNIPEG, Manitoba, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announces its second [...]
Sana Biotechnology to Present at September 2024 Investor Conferences
29/08/2024
SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its [...]
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
29/08/2024
Strong balance sheet with successful completion of upsized $179.0 million initial public offering Treatment initiated in the first patient in an investigator-initiated basket trial of AlloNK® exploring multiple [...]
Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024
29/08/2024
IRVINE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other [...]
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences
29/08/2024
SAN DIEGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]

Pages